• Home
  • Timeline
  • The Virus
  • Virus Protection
  • Vitamin D
  • Studies
  • Flu Shot
  • The Vaccines
  • Vaccine News
  • Vaccine Recovery
  • Q's?
  • Links
  • Blog
  • Radiation
  • Overall Health
  • Excess Deaths
  • Blank
  • More
    • Home
    • Timeline
    • The Virus
    • Virus Protection
    • Vitamin D
    • Studies
    • Flu Shot
    • The Vaccines
    • Vaccine News
    • Vaccine Recovery
    • Q's?
    • Links
    • Blog
    • Radiation
    • Overall Health
    • Excess Deaths
    • Blank
  • Home
  • Timeline
  • The Virus
  • Virus Protection
  • Vitamin D
  • Studies
  • Flu Shot
  • The Vaccines
  • Vaccine News
  • Vaccine Recovery
  • Q's?
  • Links
  • Blog
  • Radiation
  • Overall Health
  • Excess Deaths
  • Blank

Vapor

VaporVaporVapor

How does immunity work?

Immunity refers to how your immune system protects you from different infections, like viruses and bacteria. One way it does this is through white blood cells (also called immune cells) circulating in your blood. The main types of white blood cells are listed below.


Macrophages attack and break down germs when they enter your body. After this, they leave behind parts of the germ (called antigens), which are then attacked by certain antibodies (see below).


B lymphocytes (also called B cells) produce different types of antibodies, which are proteins that attack antigens left behind by macrophages. The first time the body is exposed to a certain infection, it can take 7 to 10 days for antibodies to form, and they are specific to that infection. The next time your body gets that infection, your B cells will quickly make those specific antibodies to fight the infection.


T lymphocytes (also called T cells) attack cells in the body that have already been infected by the bacteria or virus. After the infection has passed, your body keeps a few T cells, called memory cells, that are ready to fight that infection again if you get it.   


Immunity can be induced by natural infection or by vaccination. In both events, the body will produce antibodies which typically circulate in the body for at least a few months. In the absence of antibodies, the B and T cells can quickly produce new antibodies if exposed to the virus again. This is why antibody tests are not the best way to determine if you are protected against SARS-CoV-2. It is best to test for T cell memory of the virus. 


There is a difference in the antibodies developed from natural infection compared to vaccination. Natural infection induces an immune response against the whole virus. This includes the membrane, nucleocapsid, envelope, and all proteins including the Spike Protein. The vaccine induced antibodies target only the Spike Protein from the original strain of the virus.


The benefit of Natural Immunity is that in the event of a mutation in any segment of SARS-CoV-2, including the Spike Protein, enough of the virus will still be recognized to develop an effective and timely immune response.

Natural Immunity

Natural Immunity confers longer lasting and stronger protection than 2-dose vaccine immunity:

Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections (8/24/21)

https://www.medrxiv.org/content/10.1101/2021.08.24.21262415v1

Findings: This study demonstrated that natural immunity confers longer lasting and stronger protection against infection, symptomatic disease and hospitalization caused by the Delta variant of SARS-CoV-2, compared to the BNT162b2 two-dose vaccine-induced immunity. Individuals who were both previously infected with SARS-CoV-2 and given a single dose of the vaccine gained additional protection against the Delta variant.


Natural Immunity Triggers Better Response Against COVID - Kim Iverson, The Hill (8/30/21)

https://www.youtube.com/watch?v=6v5VrpgXPm4

A study of 700,000 people determines natural immunity has 13 times more protection against the Delta variant


Scientists identify natural SARS-CoV-2 super immunity against 23 variants (07/05/21)

https://www.news-medical.net/news/20210705/Scientists-identify-natural-SARS-CoV-2-super-immunity-against-23-variants.aspx


Natural Immunity and Covid-19: Thirty Scientific Studies to Share with Employers, Health Officials, and Politicians (10/10/21)

https://brownstone.org/articles/natural-immunity-and-covid-19-twenty-nine-scientific-studies-to-share-with-employers-health-officials-and-politicians/


122 Research Studies Affirm Naturally Acquired Immunity to Covid-19: Documented, Linked, and Quoted (10/17/21)

https://brownstone.org/articles/79-research-studies-affirm-naturally-acquired-immunity-to-covid-19-documented-linked-and-quoted/


New UK Covid Data Shows Natural Immunity Provides Better Protection Than Two Vaccines (10/19/21)

https://net-breaking.com/2021/10/19/new-uk-covid-data-shows-natural-immunity-provides-better-protection-than-two-vaccines/


Neurologist explains why unvaccinated previously infected people are less likely to spread COVID than never-infected vaccinated people (08/17/21)

https://www.theblaze.com/news/neurologist-unvaccinated-previously-infected-less-likely-to-spread-covid


Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized Spike Study (10/27/21)

https://www.medrxiv.org/content/10.1101/2021.10.27.21265574v1

Findings:  Vaccination boosts antibodies for principally targeted Spike Protein, but does not boost cross-reactive antibodies and lacks neutralization activity.


CDC Study: Natural Immunity Provides Significantly More Protection Against COVID Than Vaccination Only Study 1/20/22

https://ijr.com/cdc-study-natural-immunity-significantly-protection-covid/

Findings: Among the unvaccinated with a previous infection, the COVID-19 rate was 29 times lower in California and 14.7 times lower in New York than Vaccinated Only.


Immunological Memory Provides Long-Term Protection against Coronavirus Study 2/2/22

https://www.media.uzh.ch/en/Press-Releases/2022/Immunological-Memory.html

Research team at the University of Zurich finds long-lasting memory T cells up to a year after recovery from Covid infection.


6 Big Differences Between Natural Vs. Vaccine-Induced Immunity article 2/4/22

https://childrenshealthdefense.org/defender/differences-natural-vaccine-induced-immunity/?itm_term=home

At the time the UK government and media were pumping out a narrative that most people who were becoming infected with COVID were unvaccinated, the prestigious Lancet journal quietly revealed that, in actual fact, 89% of cases were among the vaccinated.

Viral load

Covid-19 Viral load amounts are no different among the vaccinated as compared to the unvaccinated

Among asymptomatic individuals, the vaccinated have a higher percentage with a high viral load. This means that the vaccinated are more likely to spread the virus. 


Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California (8/19/21)

https://www.medrxiv.org/content/10.1101/2021.08.19.21262139v1

Findings: 

Differences in viral loads were non-significant between unvaccinated and fully vaccinated persons overall (p = 0.99) and according to lineage (p = 0.09 – 0.78). Viral loads were significantly higher in symptomatic as compared to asymptomatic vaccine breakthrough cases (p < 0.0001), and symptomatic vaccine breakthrough infections had similar viral loads to unvaccinated infections (p = 0.64).

No Significant Difference in Viral Load Between Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Groups Infected with SARS-CoV-2 Delta Variant UC Davis study (09/28/21)

https://www.medrxiv.org/content/10.1101/2021.09.28.21264262v1

Substantial proportion of asymptomatic vaccine breakthrough cases with high viral levels


CDC and State Health Department scientists find similar or higher viral load of Covid-19 virus among the vaccinated as compared to the unvaccinated  (10/19/21)

https://aaronsiri.substack.com/p/study-destroys-justification-for

Findings: Among asymptomatic individuals, the vaccinated had a higher percentage with a high viral load.  


Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study (10/29/21)

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00648-4/fulltext

Findings: Peak viral load did not differ by vaccination status or variant type
 

Vaccine immunity

Mutation of the original Spike Protein is observed in variants

As with our most common coronaviruses, SARS-CoV-2 has evolved into dozens of variants around the world, such as Delta. Transmission of the virus is not halted by vaccination, as evidenced by viral load studies linked above, confirmed by the CDC and as warned by the inventor of mRNA tech.


The WHO admits that Covid-19 is here to stay, and experts have been saying that the virus will become just another endemic virus in our communities.  There is optimistic research that predicts the virus will most likely evolve to be much less virulent, yet there is also warning that the mass vaccination with a "leaky vaccine" could have the opposite effect, by encouraging immune escape of the virus.


We know the virus mutates, so is there a risk that a mutation could affect the "Spike Protein" antigen which the vaccines are targeting for an immune response? What effect might this have? The most recent studies are linked below. 


Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant (10/26/21)

https://www.science.org/doi/10.1126/science.abl9463?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed


The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency (10/25/21)

https://www.nature.com/articles/s41423-021-00779-5


Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized Spike Study (10/27/21)

https://www.medrxiv.org/content/10.1101/2021.10.27.21265574v1

Findings:  Vaccination boosts antibodies for principally targeted Spike Protein, but does not boost cross-reactive antibodies and lacks neutralization activity. 


Vaccine induced antibodies may outcompete naturally induced antibodies Video (03/06/21)

https://rumble.com/vl5il4-vaccine-disaster-ahead.html

In the event that the target antigen (Spike Protein) has mutated, the vaccine induced antibodies will become ineffective, yet are still very robust in the system (especially after boosters) and compete for antibody dominance. These dominant, yet ineffective antibodies will prevent the immune system from building up a proper immune response to a mutated Spike Protein.


Mass worldwide vaccination focused on the Spike Protein, increases the likely hood that the virus will mutate to escape the vaccine induced immune response. The virus can become so infectious among the vaccinated it may become uncontrollable. 

Vaccine Immunity - 3 doses vs omicron

Omicron Spike Protein has 4 mutations, Vaccines have little to no effect

As of 12/28/21 data from the UK, Denmark, USA and South Africa suggest that vaccine induced antibodies provide little to no protection against the Omicron variant. A 3rd dose (of same mRNA formula) may provide SOME short term protection for SOME, but after 10 weeks may cause MORE symptoms, than for those who are vaccine free. Could this be a sign of Antibody Dependent Enhancement (ADE)? This is when innate immunity has been impeded by the vaccine, as explained in the section above. Thankfully, the Omicron variant appears to be much more mild than previous highly transmissible strains. Also included is data showing those who had recovered from the Omicron variant, may now have immunity to Delta and other variants.


The Paucity of Evidence for Mandated Covid-19 Vaccine Boosters (12/06/21) https://web.archive.org/web/20211207001920/https://brownstone.org/articles/the-paucity-of-evidence-for-mandated-covid-19-vaccine-boosters/

Study: Pfizer; 10K participants. Third vaccine dose fails to show improvement in ANY of these basic outcomes: C19 transmission, C19 hospitalization, or C19 death, & infection rate among previously infected.


Vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster  study (12/20/21) 

https://www.medrxiv.org/content/10.1101/2021.12.20.21267966v2 

Observational study from Denmark indicates that the mRNA vaccines protect for a few weeks only but then SIGNIFICANTLY AUGMENT Omicron infectivity.


New study adds more evidence for omicron immune evasion Study (12/23/21)

https://www.sciencedaily.com/releases/2021/12/211223151542.htm

There are four new spike mutations in Omicron that help the virus evade antibodies.


Booster “Mandate” Bust? Initial UK data suggests triple Covid-19 vaccinated are at >4-fold increased risk for contracting (presumptively/largely mild?) Omicron variant infections; no data on booster impact on Omicron morbidity (12/21/21)

https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/adhocs/14107coronaviruscovid19infectionsurveyukcharacteristicsrelatedtohavinganomicroncompatibleresultinthosewhotestpositiveforcovid19


South African data continues to show omicron is a much milder disease, with ICU admissions currently at 21% of their July peak, or 79% lower, and deaths at 8% of that peak, or 92% lower. 12/20/21

https://www.spectator.co.uk/article/is-omicron-now-falling-in-south-africa-


UK report suggests booster effectiveness against symptomatic omicron decreases within 10 weeks 12/23/21

https://news.yahoo.com/uk-report-suggests-booster-effectiveness-013617409.html

Booster efficacy goes to 35%-45% in just 10 weeks. 


Coronavirus (COVID-19) Infection Survey, UK: Characteristics related to having an Omicron compatible result in those who test positive for COVID-19

https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/adhocs/14107coronaviruscovid19infectionsurveyukcharacteristicsrelatedtohavinganomicroncompatibleresultinthosewhotestpositiveforcovid19


COVID-19 Reported Patient Impact and Hospital Capacity by State

https://beta.healthdata.gov/dataset/COVID-19-Reported-Patient-Impact-and-Hospital-Capa/6xf2-c3ie


Does Omicron Represent the Beginning of the End of COVID-19? 12/28/21

https://trialsitenews.com/does-omicron-represent-the-beginning-of-the-end-of-covid-19-south-african-led-research-raises-a-glimmer-of-hope/

Omicron study data finding that this strain seems less pathogenic than Delta which may overall decrease severe disease burden. 


Studies show that the COVID vaccines damage your immune system Article 12/24/21 

https://stevekirsch.substack.com/p/new-study-shows-vaccines-must-be

At 60 days, the protection is close to zero, so if you want to maintain protection, getting vaccinated every 30 days is required.


This isn’t a vaccine at all. This is basically stimulating your immune system so it is already “geared up” to fight the virus. That’s not what a vaccine is supposed to do.


Israel Finds Fourth COVID Booster is Ineffective, While Hospitalized Omicron Patients Fare Much Better Than Delta Patients 1/17/22

https://healthpolicy-watch.news/israel-fourth-covid-booster-ineffective/

Vapor Transmission

Copyright © 2023 Vapor - All Rights Reserved.

Powered by GoDaddy